Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1992 3
1993 1
1994 2
1997 1
1998 2
1999 1
2001 1
2008 1
2010 1
2011 2
2012 3
2013 1
2014 3
2015 3
2016 5
2017 5
2018 5
2019 7
2020 4
2021 8
2022 8
2023 7
2024 2
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma.
Maesaka K, Hikita H, Tahata Y, Nishioka C, Kai M, Shirai K, Murai K, Makino Y, Saito Y, Kodama T, Ohkawa K, Miyazaki M, Nozaki Y, Yakushijin T, Sakamori R, Tatsumi N, Matsumoto K, Ishida H, Iio S, Nawa T, Kakita N, Nakahara M, Hosui A, Yoshida Y, Usui T, Imanaka K, Doi Y, Sakakibara M, Takehara T. Maesaka K, et al. Among authors: iio s. J Gastroenterol. 2025 Oct 25. doi: 10.1007/s00535-025-02308-x. Online ahead of print. J Gastroenterol. 2025. PMID: 41139139
Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma.
Maesaka K, Hikita H, Kai M, Tahata Y, Shirai K, Doi A, Murai K, Saito Y, Yamada R, Kodama T, Ohkawa K, Miyazaki M, Ishida H, Matsumoto K, Nozaki Y, Yakushijin T, Sakamori R, Tatsumi N, Iio S, Nawa T, Kakita N, Nakahara M, Hosui A, Usui T, Imanaka K, Doi Y, Sakakibara M, Yoshida Y, Tatsumi T, Takehara T. Maesaka K, et al. Among authors: iio s. J Gastroenterol Hepatol. 2025 Oct;40(10):2580-2590. doi: 10.1111/jgh.70068. Epub 2025 Sep 9. J Gastroenterol Hepatol. 2025. PMID: 40922653 Free PMC article.
IgE Plasma Cell Leukemia Harboring t(11;14) and 1q Amplification.
Nakahara W, Ogawa T, Matsunaga H, Iwasa Y, Horita M, Ikeda M, Asako M, Iio S, Iwama Y, Oka K, Ueda S. Nakahara W, et al. Among authors: iio s. Case Rep Hematol. 2023 Jun 27;2023:4747989. doi: 10.1155/2023/4747989. eCollection 2023. Case Rep Hematol. 2023. PMID: 37408875 Free PMC article.
Genomic analysis for the prediction of prognosis in small-bowel cancer.
Tsuboi A, Urabe Y, Oka S, Sumioka A, Iio S, Yuge R, Hayashi R, Kuwai T, Kitadai Y, Kuraoka K, Arihiro K, Tanaka S, Chayama K. Tsuboi A, et al. Among authors: iio s. PLoS One. 2021 May 20;16(5):e0241454. doi: 10.1371/journal.pone.0241454. eCollection 2021. PLoS One. 2021. PMID: 34014970 Free PMC article.
Prognostic impact of worsening of esophageal varices after balloon-occluded retrograde transvenous obliteration.
Shinkai K, Sakamori R, Yamada R, Tahata Y, Nozaki Y, Matsumoto K, Tawara S, Fukuda K, Yoshida Y, Tanaka S, Ito T, Doi Y, Iio S, Sakakibara M, Nakanishi F, Kodama T, Hikita H, Tatsumi T, Takehara T. Shinkai K, et al. Among authors: iio s. J Gastroenterol Hepatol. 2022 Jun;37(6):1148-1155. doi: 10.1111/jgh.15853. Epub 2022 Apr 26. J Gastroenterol Hepatol. 2022. PMID: 35430734
70 results